Monoclonal antibodies against c-Met

Details for Australian Patent Application No. 2011226103 (hide)

Owner Genmab A/S

Inventors Neijssen, Joost J.; De Goeij, Bart; Van Den Brink, Edward; Labrijn, Aran Frank; Hoet, Rene M. A.; Schuurman, Janine; Parren, Paul; Van De Winkel, Jan

Agent Watermark

Pub. Number AU-A-2011226103

PCT Pub. Number WO2011/110642

Priority PA 2010 00191 10.03.10 DK; PA 2010 00862 24.09.10 DK; 61/312,622 10.03.10 US

Filing date 10 March 2011

Wipo publication date 15 September 2011

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

27 September 2012 PCT application entered the National Phase

  PCT publication WO2011/110642 Priority application(s): WO2011/110642

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011226105-Short synthesis of tolterodine, intermediates and metabolites

2011226101-Heat-curable powder coating compositions, which after the coating has cured result in a matt surface and simple method for producing same